Following a public comment period, the Federal Trade Commission has approved a final order that settles charges that Grifols S.A.’s acquisition of Biotest US Corporation is anticompetitive and violates federal antitrust law. Grifols is a global healthcare company based in Spain. Biotest US is a healthcare company based in Florida. According to the complaint, which […]
Tag Archives: Health Care Bureau of Competition Competition Merger Horizontal Restraints
FTC Requires Grifols S.A. to Divest Assets as Condition of Acquiring Biotest US Corporation
The Federal Trade Commission will require Spain-based global healthcare company Grifols S.A. to divest blood plasma collection centers in three U.S. cities, among other conditions, as part of a settlement resolving charges that Grifols’ acquisition of Florida-based Biotest US Corporation is anticompetitive and violates federal antitrust law. The products at issue, competition concerns and economic implications […]